Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IN › Indianapolis › NPI 1619946746
Supplier

Indiana University Health, INC

Indiana University Health, INC was paid $556K by Medicaid between Jan 2018 and Nov 2024, across 10 billing codes. Its largest line is J7518, Mycophenolic acid, oral, 180 mg — 43% of everything it billed.

33Billing provider infoINDIANA UNIVERSITY HEALTH, INC
INDIANAPOLIS, IN 46202
33aNPI1619946746assigned 03/14/2006
28Total paid$556K
24GClaims51,280
24DCodes billed10
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Community/Retail Pharmacy providers in Indiana

Rank by total paid#1 of 65
Median peer was paid$0.00
This provider vs. median0.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official ALVEY, JENNIFER controls 17+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20187,453$139K
20197,345$148K
20208,601$79K
20218,687$111K
20228,414$46K
20237,065$24K
2024incomplete3,715$11K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
J7518 Mycophenolic acid, oral, 180 mg 43% 8,060 7,156 $240K
J7507 Tacrolimus, immediate release, oral, 1 mg 27% 13,651 10,778 $150K
J7520 Sirolimus, oral, 1 mg 18% 2,974 2,584 $102K
J7503 Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg 8.9% 539 452 $49K
J7517 Mycophenolate mofetil, oral, 250 mg 2.4% 2,747 2,447 $13K
J7515 Cyclosporine, oral, 25 mg <1% 26 24 $1K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 503 448 $56.91
Q0511 Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period <1% 9,509 8,611 $43.20
Q0512 Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period <1% 13,255 8,562 $35.20
Q0510 Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant 0% 16 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialALVEY, JENNIFER (SVP AND CFO)
Same official

Other billing entities under ALVEY, JENNIFER

Full network →
ProviderLocationPaid
Indiana University Health, INCIndianapolis, IN$178.13M
Indiana University Health INCIndianapolis, IN$111.35M
Indiana University Health INCIndianapolis, IN$75.62M
Indiana University Health, INCIndianapolis, IN$4.54M
Indiana University Health, INCIndianapolis, IN$1.26M
Indiana University Health, INCMuncie, IN$416K
Indiana University Health, INCCarmel, IN$415K
Indiana University Health, INCBloomington, IN$339K
Indiana University Health, INCAvon, IN$326K
Indiana University Health, INCLafayette, IN$262K
Indiana University Health, INCGreenwood, IN$92K
Indiana University Health INC.Indianapolis, IN$80K
Indiana University Health INCFishers, IN$80K
Indiana University Health, INCIndianapolis, IN$28K
Indiana University Health, INCIndianapolis, IN$3K
Indiana University Health, INCIndianapolis, IN$81.39
Indiana University Health INCIndianapolis, IN$0.00

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.